Clorazepate dipotassium
Clorazepate Dipotassium is a prescription benzodiazepine medication available as oral tablets in strengths of 3.75 mg, 7.5 mg, and 15 mg. It is used to treat anxiety disorders and certain seizure types. Manufactured by ANI Pharmaceuticals, Inc., it is classified as a Schedule CIV controlled substance. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Clorazepate Dipotassium is a prescription benzodiazepine medication available as oral tablets in strengths of 3.75 mg, 7.5 mg, and 15 mg. It is used to treat anxiety disorders and certain seizure types. Manufactured by ANI Pharmaceuticals, Inc., it is classified as a Schedule CIV controlled substance. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Clorazepate dipotassium",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Clorazepate dipotassium — ANDA 075731 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075731"
}
]
|
| identifier | ANDA075731 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Clorazepate dipotassium |
